Bull Run

India's AI-powered stock screener for NSE & BSE. 5,000+ stocks with fundamentals and real-time analysis.

info@bullrun.co.in

Navigate

  • Home
  • Smart Screener
  • Stock Battle Arena
  • Watchlist
  • Go Premium

Tools

  • Advanced Stock Screening
  • Stock Comparison Tool
  • Personal Watchlist
  • Ask AI Assistant
  • Browse All Stocks
  • IPO GMP Tracker
  • Market News & Blog

Indices

  • All Indices
  • Nifty 50 Stocks
  • Sensex Stocks
  • Nifty Bank
  • Nifty IT
  • Nifty Pharma
  • Nifty Midcap 100

Screeners

  • Top Dividend Stocks
  • Debt Free Stocks
  • Undervalued Stocks
  • High ROE Stocks
  • Low PE Stocks
  • Top Rated Stocks
  • Large Cap Stocks
  • Compare Stocks
  • Browse by Sector

Browse Stocks by Sector

View All →
Non Banking Financial Company (NBFC)PharmaceuticalsComputers - Software & ConsultingIndustrial ProductsCivil ConstructionAuto Components & EquipmentsSpecialty ChemicalsOther Financial ServicesIT Enabled ServicesPackagingHotels & ResortsCommodity ChemicalsOther Electrical EquipmentGarments & ApparelsPaper & Paper ProductsSoftware ProductsPackaged FoodsCement & Cement ProductsSugarHeavy Electrical EquipmentHospitalEdible OilPower GenerationHealthcare Service Provider
© 2026 Bull Run. All rights reserved.
AboutBlogPrivacy PolicyTerms of Service

Disclaimer: Ratings and scores are generated algorithmically from publicly available market data for educational and informational purposes only. They do not constitute investment advice or solicitation to buy/sell securities. Bull Run is not a SEBI-registered Research Analyst or Investment Adviser.

  1. Home
  2. /
  3. Sectors
  4. /
  5. Healthcare Service Provider
  6. /
  7. Suraksha Diagnostic Ltd
Financial RatiosPE RatioShareholdingDividendQuarterly ResultsBalance SheetProfit & LossCash Flow
HomeStocksHealthcare Service ProviderSuraksha Diagnostic Ltd

Suraksha Diagnostic Ltd Stock Price Today (NSE: SURAKSHA)

Suraksha Diagnostic Ltd

SURAKSHAHealthcare Service Provider
₹227.95₹12.70 (5.12%)↓
As on 30 Mar 2026, 12:05 pm ISTMarket Closed

Fundamental Score

...

Suraksha Diagnostic Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Suraksha Diagnostic Ltd share price today is ₹227.95, down 5.12% on NSE/BSE as of 30 March 2026. Suraksha Diagnostic Ltd (SURAKSHA) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹1.53K (Cr). The 52-week high for SURAKSHA share price is ₹352.50 and the 52-week low is ₹232.70. At a P/E ratio of 48.05x, SURAKSHA is currently trading above its industry average P/E of 39.28x. The company has a Return on Equity (ROE) of 16.46% and a debt-to-equity ratio of 0.51.

Suraksha Diagnostic Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
₹0.00
Low
₹0.00
Volume
0
Change
-5.12%

Returns & Performance

Average

ROE

16.46%
Good

ROCE

17.84%
Excellent

OPM (5Y)

26.87%

Div Yield

0.00%

Suraksha Diagnostic Ltd Valuation Check

Poor

P/E Ratio

48.05x
Poor

Industry P/E

39.28x
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Market Cap

1.53K (Cr)

Growth Engine

Poor

Profit Growth (Q)

-13.06%
Good

Sales Growth (Q)

17.95%
Poor

Sales Growth (5Y)

9.86%
Poor

EPS Growth (5Y)

-50.98%
Excellent

Profit Growth (5Y)

16.38%

Balance Sheet Health

Poor

Debt to Equity

0.51x
Excellent

Int. Coverage

5.39x

Free Cash Flow (5Y)

102.08 (Cr)

Shareholding

Excellent

Promoter

48.98%
Good

FII

13.73%
Excellent

DII

21.98%
Excellent

Pledged

0.00%

Institutional Deep-Dive

Bull Run Research Hub

Suraksha Diagnostic Share Price: A Financial Analysis

In the evolving landscape of healthcare service providers, a crucial trend is the increased demand for preventative diagnostics driven by a growing awareness of proactive health management. This analysis examines the financial standing of Suraksha Diagnostic Ltd, focusing on its key metrics. Currently, the Suraksha Diagnostic share price stands at ₹288.3500061035156. This analysis is part of an 80-parameter fundamental audit verified by Sweta Mishra.

One of the first indicators of a company's health is its Price-to-Earnings (PE) ratio. Suraksha Diagnostic Ltd reports a PE of 48.05. While PE ratios vary across sectors, it's important to compare this figure to its peers. Considering Aspira Pathlab & Diagnostics Limited, understanding the management quality and future growth prospects becomes paramount to justify a potentially higher valuation. Are the management decisions driving superior operational efficiency and market penetration compared to competitors? These factors influence investor confidence.

Return on Capital Employed (ROCE) is another crucial metric. Suraksha Diagnostic Ltd exhibits a ROCE of 17.84%. This percentage illustrates how efficiently the company is generating profits from its invested capital. A strong ROCE, like the one observed here, contributes significantly to the development of a company's economic moat. Specifically, a consistent and high ROCE allows Suraksha Diagnostic to reinvest profits strategically, expanding its network of diagnostic centers, improving technology, and ultimately reinforcing its competitive advantage within the market.

Finally, a comparative analysis with sector peers such as Gian Life Care Ltd and Samsrita Labs Ltd is crucial to understanding Suraksha Diagnostic's relative position. Evaluating factors like revenue growth, profitability margins, and debt levels within this context paints a more comprehensive picture of the company's financial health and its ability to navigate the challenges and opportunities within the diagnostic services sector.

SM
Analysis by Sweta Mishra
SEBI Registered Research Analyst

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Suraksha Diagnostic Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of SURAKSHA across key market metrics for learning purposes.

Positive Indicators

9 factors identified

Strong Return on Equity (16.46%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Excellent ROCE Performance (17.84%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Strong Operating Margins (26.87%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Strong Revenue Growth (17.95%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Strong Profit Growth Track Record (16.38% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Strong Interest Coverage (5.39x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Strong Cash Generation (₹102.08 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Strong Institutional Confidence (FII+DII: 35.71%)

Observation: Significant professional investor participation.

Analysis: High institutional holding often signals thorough due diligence.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

4 factors identified

Premium Valuation Risk (P/E: 48.05x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Profit Decline Concern (-13.06%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Weak Earnings Growth (-50.98% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Suraksha Diagnostic Ltd Financial Statements

Comprehensive financial data for Suraksha Diagnostic Ltd including income statement, balance sheet and cash flow

About SURAKSHA (Suraksha Diagnostic Ltd)

Suraksha Diagnostic Ltd is a comprehensive healthcare service provider dedicated to delivering accurate, reliable, and timely diagnostic testing to patients across India. As a trus...ted name in the diagnostic landscape, Suraksha is committed to utilizing state-of-the-art technology and employing highly skilled professionals to ensure the highest standards of quality. From routine blood tests to advanced imaging, Suraksha offers a broad spectrum of diagnostic services to cater to the diverse needs of its patients and healthcare partners. Driven by a patient-centric approach, Suraksha aims to empower individuals to make informed decisions about their health through accessible and affordable diagnostic solutions. Suraksha Diagnostic's commitment extends beyond simply providing testing services. They are dedicated to employing cutting-edge methodologies and sophisticated equipment to analyze biological samples and produce detailed images. Specifically, the pathology department examines blood, tissues, and other body fluids using a range of techniques, from traditional staining methods to advanced molecular diagnostics. The radiology department utilizes sophisticated imaging equipment, like MRI and CT scans, to provide detailed views of internal organs and structures. This dedication to technology and expertise allows Suraksha to play a crucial role in early disease detection, accurate diagnosis, and effective treatment planning. In addition to its technical prowess, Suraksha Diagnostic prides itself on its unwavering commitment to ethical practices, patient safety, and customer satisfaction. The company adheres to stringent quality control measures and participates in external quality assurance programs to ensure the accuracy and reliability of its test results. Suraksha strives to create a welcoming and comfortable environment for its patients, with a focus on personalized attention and compassionate care. By combining cutting-edge technology with a human touch, Suraksha Diagnostic is committed to being a trusted partner in promoting the health and well-being of the communities it serves.

Company Details

Symbol:SURAKSHA
Industry:Healthcare Service Provider
Sector:Healthcare Service Provider
Website:https://www.surakshanet.com

Key Leadership

Dr. Somnath Chatterjee
Executive Chairman & Joint MD
Ms. Ritu Mittal
Joint MD, CEO & Executive Director
Mr. Ravindra K. S.
Chief Financial Officer

Latest News

Adani group, Suraksha, Sunteck Realty submit EOI to acquire debt-laden HDIL - Times of India
Times of India• 8/4/2020
Adani, Sunteck Realty, Suraksha Asset show interest in acquiring HDIL - Business Standard
Business Standard• 8/4/2020

SURAKSHA Share Price: Frequently Asked Questions

What is the current share price of Suraksha Diagnostic Ltd (SURAKSHA)?

As of 30 Mar 2026, 12:05 pm IST, Suraksha Diagnostic Ltd share price is ₹227.95. The SURAKSHA stock has a market capitalisation of ₹1.53K (Cr) on NSE/BSE.

Is SURAKSHA share price Overvalued or Undervalued?

SURAKSHA share price is currently trading at a P/E ratio of 48.05x, compared to the industry average of 39.28x. Based on this relative valuation, the Suraksha Diagnostic Ltd stock appears to be Overvalued against its sector peers.

What is the 52-week high and low of SURAKSHA share price?

The 52-week high of SURAKSHA share price is ₹352.50 and the 52-week low is ₹232.70. These values are updated daily from NSE/BSE price data.

What factors affect the Suraksha Diagnostic Ltd share price?

Key factors influencing SURAKSHA share price include quarterly earnings growth (Sales Growth: 17.95%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Suraksha Diagnostic Ltd a good stock for long-term investment?

Suraksha Diagnostic Ltd shows a 5-year Profit Growth of 16.38% and an ROE of 16.46%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.51 before investing in SURAKSHA shares.

How does Suraksha Diagnostic Ltd compare with its industry peers?

Suraksha Diagnostic Ltd competes with major peers in the Healthcare Service Provider. Investors should compare SURAKSHA share price P/E of 48.05x and ROE of 16.46% against the industry averages to determine competitive standing.

What is the P/E ratio of SURAKSHA and what does it mean?

SURAKSHA share price has a P/E ratio of 48.05x compared to the industry average of 39.28x. Investors pay ₹48 for every ₹1 of annual earnings.

How is SURAKSHA performing according to Bull Run's analysis?

SURAKSHA has a Bull Run fundamental score of 47.1/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.

What sector and industry does SURAKSHA belong to?

SURAKSHA operates in the Healthcare Service Provider industry. This classification helps understand the competitive landscape and sector-specific trends affecting Suraksha Diagnostic Ltd share price.

What is Return on Equity (ROE) and why is it important for SURAKSHA?

SURAKSHA has an ROE of 16.46%, which indicates excellent management efficiency. ROE measures how efficiently Suraksha Diagnostic Ltd generates profits from shareholders capital.

How is SURAKSHA debt-to-equity ratio and what does it indicate?

SURAKSHA has a debt-to-equity ratio of 0.51, which indicates moderate leverage that should be monitored.

What is SURAKSHA dividend yield and is it a good dividend stock?

SURAKSHA offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Suraksha Diagnostic Ltd shares.

How has SURAKSHA share price grown over the past 5 years?

SURAKSHA has achieved 5-year growth rates of: Sales Growth 9.86%, Profit Growth 16.38%, and EPS Growth -50.98%.

What is the promoter holding in SURAKSHA and why does it matter?

Promoters hold 48.98% of SURAKSHA shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Suraksha Diagnostic Ltd.

What is SURAKSHA market capitalisation category?

SURAKSHA has a market capitalisation of ₹1534 crores, placing it in the Small-cap category.

How volatile is SURAKSHA stock?

SURAKSHA has a beta of N/A. A beta > 1 suggests the Suraksha Diagnostic Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is SURAKSHA operating profit margin trend?

SURAKSHA has a 5-year average Operating Profit Margin (OPM) of 26.87%, indicating the company's operational efficiency.

How is SURAKSHA quarterly performance?

Recent quarterly performance shows Suraksha Diagnostic Ltd YoY Sales Growth of 17.95% and YoY Profit Growth of -13.06%.

What is the institutional holding pattern in SURAKSHA?

SURAKSHA has FII holding of 13.73% and DII holding of 21.98%. Significant institutional holding often suggests professional confidence in the Suraksha Diagnostic Ltd stock.

HomeScreenerBattleWatchlist

Frequently Asked Questions about Suraksha Diagnostic Ltd

What is the current share price of Suraksha Diagnostic Ltd?

Suraksha Diagnostic Ltd (SURAKSHA) trades at ₹227.95 on NSE and BSE. Market cap ₹1.53K (Cr). Educational data only.

What is the P/E ratio of Suraksha Diagnostic Ltd?

Suraksha Diagnostic Ltd has a P/E of 48.05x vs industry average 39.28x.

What is the Bull Run score for Suraksha Diagnostic Ltd?

Suraksha Diagnostic Ltd has a Bull Run score of 47.1/100 based on 25+ financial parameters.

Does Suraksha Diagnostic Ltd pay dividends?

Suraksha Diagnostic Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Suraksha Diagnostic Ltd?

Suraksha Diagnostic Ltd has ROE of 16.46%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Suraksha Diagnostic Ltd?

Suraksha Diagnostic Ltd has debt-to-equity of 0.51.

Is Suraksha Diagnostic Ltd a good investment?

Bull Run gives Suraksha Diagnostic Ltd a score of 47.1/100. This is not investment advice — consult a SEBI-registered advisor.